Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdimFlu-V Immunogenicity and Safety in Healthy Children and Adolescents
NCT01755364Phase 3Completed
- Sponsor
- Adimmune
- Start
- Nov 2012
- Primary completion
- Jan 2013
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus vaccine, split virion in influenza, sponsored by Adimmune. Started Nov 2012; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01755364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755364.